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• Osteoarthritis (OA) is a chronic and 
progressive degenerative joint 
disease. 
Surgical preparation of subjects: 
• Currently, no curative therapeutics 
are available for the disease, only 
ones to help manage the pain. 
• Early pilot studies demonstrated 
feasibility of longitudinal 
monitoring of immune responses 
in the MMT model of OA. 
• We aim to identify early immune 
biomarkers that may be indicative 
of disease status.
• Possible Sex Differences with OA treatment
Next Steps: 





Figure 1. A joint with OA vs. a Normal joint. This disease 







Figure 2. MMT Model in the rat. We expose the joint space 
and meniscus on the medial side and transect it. This 




Figure  3. MicroCT Analysis. (A) Contrast enhancing in healthy and diseased 
cartilage. (B) 2D greyscale image of a medial Left section in a Y sagittal view. (C) 
3D representations of the cartilage in medial and lateral tibial plateau. The medial 
tibial plateau can then be sectioned into thirds: lateral, central and medial. This 
allows for more localized evaluations. 
Figure 4. Immune Response Analysis. (A) Blood
collection schematic. (B) Synovial fluid aspiration
schematic. (C) Using flow cytometry blood samples are
ran and circulating immune cell levels are measured. (D)
Luminex allows us to measure circulating inflammatory
cytokine levels in both the blood and the SF.
Figure  5. There may be a difference among males and females. (A) 
Average cartilage volume of the medial third with intra-articular 
treatment for MMT females (MMT + mdHACM (n = 3) and MMT + saline 
(n =3)) and males (MMT + mdHACM (n = 3) and MMT + saline (n = 
2)).(B) 3D representations of the cartilage in medial tibial plateau for the 
same subjects depicted on the graph. 
Figure 6. Surface 
Roughness. Using a 
MATLAB program 
developed by our lab, 
we will calculate 
cartilage surface 
roughness. 
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• Linear and nonlinear multivariate regression techniques to 
identify immune biomarkers that are correlated with the 
cartilage surface roughness, volume, thickness, and X-ray 
attenuation of the articular cartilage at the end point. 
• Complete microCT cartilage 
evaluations:
Ø n=7-8 per group for 3 week 
treatment study (with 
females & males)
Ø n=9-10 per group for 6 week 
MMT only study (with 
females & males) 
